149 related articles for article (PubMed ID: 25444956)
1. HIF1α expression under normoxia in prostate cancer--which pathways to target?
Ranasinghe WK; Baldwin GS; Bolton D; Shulkes A; Ischia J; Patel O
J Urol; 2015 Mar; 193(3):763-70. PubMed ID: 25444956
[TBL] [Abstract][Full Text] [Related]
2. ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells.
Zou C; Yu S; Xu Z; Wu D; Ng CF; Yao X; Yew DT; Vanacker JM; Chan FL
J Pathol; 2014 May; 233(1):61-73. PubMed ID: 24425001
[TBL] [Abstract][Full Text] [Related]
3. The role of hypoxia-inducible factor 1α in determining the properties of castrate-resistant prostate cancers.
Ranasinghe WK; Xiao L; Kovac S; Chang M; Michiels C; Bolton D; Shulkes A; Baldwin GS; Patel O
PLoS One; 2013; 8(1):e54251. PubMed ID: 23342109
[TBL] [Abstract][Full Text] [Related]
4. Expression of hypoxia inducible factor-1 alpha in matched hormone naive and castrate resistant prostate cancer specimens.
Elsberger B; Lankston L; Orange C; Underwood MA; Edwards J
Cancer Biomark; 2010-2011; 8(1):1-9. PubMed ID: 21896985
[TBL] [Abstract][Full Text] [Related]
5. Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha).
Anastasiadis AG; Ghafar MA; Salomon L; Vacherot F; Benedit P; Chen MW; Shabsigh A; Burchardt M; Chopin DK; Shabsigh R; Buttyan R
J Cancer Res Clin Oncol; 2002 Jul; 128(7):358-62. PubMed ID: 12136249
[TBL] [Abstract][Full Text] [Related]
6. [Over-expression of Hypoxia-inducible factor 1alpha increases invasive potency of LNCaP cells in vitro].
Luo Y; He DL; Ning L; Shen SL; Li L; Li X
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2285-8. PubMed ID: 17064578
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of endogenous erythropoietin expression by DLBS6747, a bioactive fraction of Ipomoea batatas L. leaves, via increasing HIF1α transcription factor in HEK293 kidney cells.
Berlian G; Tandrasasmita OM; Tjandrawinata RR
J Ethnopharmacol; 2019 May; 235():190-198. PubMed ID: 30685435
[TBL] [Abstract][Full Text] [Related]
8. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-independent downregulation of hypoxia-inducible factor 1 targets by androgen deprivation therapy in prostate cancer.
Ragnum HB; Røe K; Holm R; Vlatkovic L; Nesland JM; Aarnes EK; Ree AH; Flatmark K; Seierstad T; Lilleby W; Lyng H
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):753-60. PubMed ID: 24035332
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor-1 in human breast and prostate cancer.
Kimbro KS; Simons JW
Endocr Relat Cancer; 2006 Sep; 13(3):739-49. PubMed ID: 16954428
[TBL] [Abstract][Full Text] [Related]
11. Ion channel TRPM8 promotes hypoxic growth of prostate cancer cells via an O2 -independent and RACK1-mediated mechanism of HIF-1α stabilization.
Yu S; Xu Z; Zou C; Wu D; Wang Y; Yao X; Ng CF; Chan FL
J Pathol; 2014 Dec; 234(4):514-25. PubMed ID: 25065497
[TBL] [Abstract][Full Text] [Related]
12. Expression and stability of hypoxia inducible factor 1α in osteosarcoma.
El Naggar A; Clarkson P; Zhang F; Mathers J; Tognon C; Sorensen PH
Pediatr Blood Cancer; 2012 Dec; 59(7):1215-22. PubMed ID: 22544557
[TBL] [Abstract][Full Text] [Related]
13. [Role of beta-catenin signaling pathway in EMT of human prostate cancer induced by HIF-1alpha].
Luo Y; He DL; Jiang YG; Ning L; Shen SL; Zhao JH; Cui XH
Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(16):1131-6. PubMed ID: 20646434
[TBL] [Abstract][Full Text] [Related]
14. Normoxic stabilization of hypoxia-inducible factor-1alpha by modulation of the labile iron pool in differentiating U937 macrophages: effect of natural resistance-associated macrophage protein 1.
Knowles HJ; Mole DR; Ratcliffe PJ; Harris AL
Cancer Res; 2006 Mar; 66(5):2600-7. PubMed ID: 16510578
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel maintains its cytotoxic activity under hypoxic conditions in prostate cancer cells.
Forde JC; Perry AS; Brennan K; Martin LM; Lawler MP; Lynch TH; Hollywood D; Marignol L
Urol Oncol; 2012; 30(6):912-9. PubMed ID: 21176881
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells.
Mirzoeva S; Kim ND; Chiu K; Franzen CA; Bergan RC; Pelling JC
Mol Carcinog; 2008 Sep; 47(9):686-700. PubMed ID: 18240292
[TBL] [Abstract][Full Text] [Related]
18. Melatonin down-regulates HIF-1 alpha expression through inhibition of protein translation in prostate cancer cells.
Park JW; Hwang MS; Suh SI; Baek WK
J Pineal Res; 2009 May; 46(4):415-21. PubMed ID: 19552765
[TBL] [Abstract][Full Text] [Related]
19. Expression and hypoxic regulation of hif1alpha and hif2alpha during early blood and endothelial cell differentiation in chick.
Ota K; Nagai H; Sheng G
Gene Expr Patterns; 2007 Aug; 7(7):761-6. PubMed ID: 17625986
[TBL] [Abstract][Full Text] [Related]
20. DNA strand breaks and hypoxia response inhibition mediate the radiosensitisation effect of nitric oxide donors on prostate cancer under varying oxygen conditions.
Stewart GD; Nanda J; Katz E; Bowman KJ; Christie JG; Brown DJ; McLaren DB; Riddick AC; Ross JA; Jones GD; Habib FK
Biochem Pharmacol; 2011 Jan; 81(2):203-10. PubMed ID: 20888325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
